$IEP Cashflow Statement | Understand Stock

$IEP

$5.56 -$0.19 (3.3%) Close

$IEP Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated statements of cash flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash flows from operating activities:
Net loss
Adjustments to reconcile net loss to net cash provided by operating activities:
Net loss from securities transactions
Purchases of securities
Proceeds from sales of securities
Payments to cover securities sold, not yet purchased
Proceeds from securities sold, not yet purchased
Changes in receivables and payables relating to securities transactions
Changes in derivative assets and liabilities
Loss (gain) on disposition of assets, net
Depreciation and amortization
Loss on deconsolidation of subsidiary
Credit loss expense
Impairment
Deferred taxes
Inventory write-down
Other, net
Changes in other operating assets and liabilities:
Accounts receivable, net
Related party note receivable
Inventories
Other assets
Accounts payable
Accrued expenses and other liabilities

Net cash (used in) provided by operating activities
Cash flows from investing activities:
Capital expenditures
Turnaround expenditures
Acquisition of businesses, net of cash acquired
Proceeds from sale of investments
Proceeds from sale of equity investment
Proceeds from disposition of businesses and assets
Related party note receivable payments and distributions, net
Other, net
Net cash (used in) provided by investing activities

Cash flows from financing activities:
Investment segment contributions from non-controlling interests
Investment segment distributions to non-controlling interests
Partnership contributions
Partnership distributions
Proceeds from sale of (purchase of) additional interests in consolidated subsidiaries
Dividends and distributions to non-controlling interests in subsidiaries
Proceeds from Holding Company senior notes
Repayments of Holding Company senior notes
Repurchase of senior notes held in treasury
Proceeds from subsidiary borrowings
Repayments of subsidiary borrowings
Other, net
Net cash used in financing activities
Effect of exchange rate changes on cash and cash equivalents and restricted cash and restricted cash equivalents
Net (decrease) increase in cash and cash equivalents and restricted cash and restricted cash equivalents
Cash and cash equivalents and restricted cash and restricted cash equivalents, beginning of period
Cash and cash equivalents and restricted cash and restricted cash equivalents, end of period

Comments